Collagen Solutions PLC (LON:COS) fell 2.8% during trading on Tuesday . The company traded as low as GBX 3.45 ($0.05) and last traded at GBX 3.45 ($0.05), 100,000 shares were traded during trading. A decline of 66% from the average session volume of 293,832 shares. The stock had previously closed at GBX 3.55 ($0.05).
The firm has a market capitalization of $16.11 million and a PE ratio of -7.26. The business’s fifty day moving average price is GBX 3.59 and its 200 day moving average price is GBX 3.92. The company has a quick ratio of 1.25, a current ratio of 1.44 and a debt-to-equity ratio of 16.26.
Collagen Solutions Company Profile (LON:COS)
Collagen Solutions plc sources, develops, manufactures, and supplies medical grade collagen components and biomaterials for use in research, regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. It offers collagen soluble collagen, collagen powders, fibrillars, collagen gels, freeze dried collagen, and other products for use in orthopaedic, sports medicine, dental, wound care, cardiovascular, general, plastic, and reconstructive surgeries, as well as 3D cell culture research; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials.
See Also: What is Cost of Debt?
Receive News & Ratings for Collagen Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Collagen Solutions and related companies with MarketBeat.com's FREE daily email newsletter.